These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29763888)

  • 1. Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside.
    Zhang Y; Tan S; Xu J; Wang T
    Cell Physiol Biochem; 2018; 47(1):1-10. PubMed ID: 29763888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen therapy as a potential therapeutic intervention in heart disease: from the past evidence to future application.
    Saengsin K; Sittiwangkul R; Chattipakorn SC; Chattipakorn N
    Cell Mol Life Sci; 2023 Jun; 80(6):174. PubMed ID: 37269385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-based therapies in cardiovascular and metabolic diseases: past, present and future.
    Murphy AJ; Febbraio MA
    Nat Rev Immunol; 2021 Oct; 21(10):669-679. PubMed ID: 34285393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine.
    Ohta S
    Pharmacol Ther; 2014 Oct; 144(1):1-11. PubMed ID: 24769081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Approach for the Prevention and Treatment of Cardiovascular Disorders. Molecular Hydrogen Significantly Reduces the Effects of Oxidative Stress.
    LeBaron TW; Kura B; Kalocayova B; Tribulova N; Slezak J
    Molecules; 2019 May; 24(11):. PubMed ID: 31159153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside.
    Xie F; Song Y; Yi Y; Jiang X; Ma S; Ma C; Li J; Zhanghuang Z; Liu M; Zhao P; Ma X
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases.
    Hu Y; Li W; Cheng X; Yang H; She ZG; Cai J; Li H; Zhang XJ
    Circ Res; 2024 Jun; 135(1):222-260. PubMed ID: 38900855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preventive and therapeutic effects of molecular hydrogen in ocular diseases and injuries where oxidative stress is involved.
    Cejka C; Kubinova S; Cejkova J
    Free Radic Res; 2019 Mar; 53(3):237-247. PubMed ID: 30773939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.
    Zhang Y; Zhang XJ; Li H
    Curr Drug Targets; 2017; 18(15):1754-1778. PubMed ID: 26240052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular hydrogen: An inert gas turns clinically effective.
    Ostojic SM
    Ann Med; 2015 Jun; 47(4):301-4. PubMed ID: 25936365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foundations of Immunometabolism and Implications for Metabolic Health and Disease.
    Hotamisligil GS
    Immunity; 2017 Sep; 47(3):406-420. PubMed ID: 28930657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases.
    Ohno K; Ito M; Ichihara M; Ito M
    Oxid Med Cell Longev; 2012; 2012():353152. PubMed ID: 22720117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells in human and experimental cardiometabolic diseases.
    Shi GP; Bot I; Kovanen PT
    Nat Rev Cardiol; 2015 Nov; 12(11):643-58. PubMed ID: 26259935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen Gas from Inflammation Treatment to Cancer Therapy.
    Wu Y; Yuan M; Song J; Chen X; Yang H
    ACS Nano; 2019 Aug; 13(8):8505-8511. PubMed ID: 31329427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular hydrogen attenuates hypoxia/reoxygenation injury of intrahepatic cholangiocytes by activating Nrf2 expression.
    Yu J; Zhang W; Zhang R; Jiang G; Tang H; Ruan X; Ren P; Lu B
    Toxicol Lett; 2015 Nov; 238(3):11-9. PubMed ID: 26276082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases.
    Dong WS; Hu C; Hu M; Gao YP; Hu YX; Li K; Ye YJ; Zhang X
    Cell Commun Signal; 2024 Aug; 22(1):389. PubMed ID: 39103830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Hydrogen as a Neuroprotective Agent.
    Iketani M; Ohsawa I
    Curr Neuropharmacol; 2017; 15(2):324-331. PubMed ID: 27281176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
    Matsuda M; Shimomura I
    Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research advances on preventive and therapeutic effects of hydrogen on cardiovascular and cerebrovascular diseases and underlying mechanisms].
    Xue JL; Song GH; Qin SC
    Sheng Li Xue Bao; 2018 Oct; 70(5):557-564. PubMed ID: 30377695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases.
    Bernardi S; Marcuzzi A; Piscianz E; Tommasini A; Fabris B
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30558209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.